VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

SOHO 2018 | The unmet needs in low-risk MDS

Speaking from the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting, held in Houston, TX, David Steensma, MD, of the Dana-Farber Cancer Institute, Boston, MA, highlights the unmet needs in low-risk myelodysplastic syndromes (MDS) currently. Dr Steensma discusses relapse following hypomethylating agent treatment, transfusion-dependence and iron overload, and those with low neutrophil and platelet counts.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter